208 related articles for article (PubMed ID: 30648824)
1. Role of Adiponectin in prostate cancer.
Hu X; Hu C; Zhang C; Zhang M; Long S; Cao Z
Int Braz J Urol; 2019; 45(2):220-228. PubMed ID: 30648824
[TBL] [Abstract][Full Text] [Related]
2. Obesity and prostate cancer: a role for adipokines.
Mistry T; Digby JE; Desai KM; Randeva HS
Eur Urol; 2007 Jul; 52(1):46-53. PubMed ID: 17399889
[TBL] [Abstract][Full Text] [Related]
3. Adipose Tissue, Obesity and Adiponectin: Role in Endocrine Cancer Risk.
Tumminia A; Vinciguerra F; Parisi M; Graziano M; Sciacca L; Baratta R; Frittitta L
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212761
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin inhibits VEGF-A in prostate cancer cells.
Gao Q; Zheng J; Yao X; Peng B
Tumour Biol; 2015 Jun; 36(6):4287-92. PubMed ID: 25586350
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin as a Potential Therapeutic Target for Prostate Cancer.
Karnati HK; Panigrahi MK; Li Y; Tweedie D; Greig NH
Curr Pharm Des; 2017; 23(28):4170-4179. PubMed ID: 28183249
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin: Its role in obesity-associated colon and prostate cancers.
Muppala S; Konduru SKP; Merchant N; Ramsoondar J; Rampersad CK; Rajitha B; Mukund V; Kancherla J; Hammond A; Barik TK; Mannarapu M; Alam A; Basha R; Bramhachari PV; Verma D; Sushma PS; Pattnaik S; Nagaraju GP
Crit Rev Oncol Hematol; 2017 Aug; 116():125-133. PubMed ID: 28693794
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin and breast cancer.
Chen X; Wang Y
Med Oncol; 2011 Dec; 28(4):1288-95. PubMed ID: 20625941
[TBL] [Abstract][Full Text] [Related]
8. Adipokines and Their Receptors Are Widely Expressed and Distinctly Regulated by the Metabolic Environment in the Prostate of Male Mice: Direct Role Under Normal and Tumoral Conditions.
Sarmento-Cabral A; L-López F; Luque RM
Endocrinology; 2017 Oct; 158(10):3540-3552. PubMed ID: 28938461
[TBL] [Abstract][Full Text] [Related]
9. [Advances on the influence of adipose tissue on prostate cancer].
López Fontana C; Maselli Artola ME; Vanrell Rodríguez MC; Di Milta Mónaco NA; Pérez Elizalde R; López Laur JD
Actas Urol Esp; 2009 Mar; 33(3):242-8. PubMed ID: 19537061
[TBL] [Abstract][Full Text] [Related]
10. The effects of beta(3)-adrenoceptor agonist CL-316,243 on adiponectin, adiponectin receptors and tumor necrosis factor-alpha expressions in adipose tissues of obese diabetic KKAy mice.
Fu L; Isobe K; Zeng Q; Suzukawa K; Takekoshi K; Kawakami Y
Eur J Pharmacol; 2008 Apr; 584(1):202-6. PubMed ID: 18304529
[TBL] [Abstract][Full Text] [Related]
11. New insights into anticarcinogenic properties of adiponectin: a potential therapeutic approach in breast cancer?
Delort L; Jardé T; Dubois V; Vasson MP; Caldefie-Chézet F
Vitam Horm; 2012; 90():397-417. PubMed ID: 23017724
[TBL] [Abstract][Full Text] [Related]
12. Serum adiponectin and leptin levels are useful markers for prostate cancer screening after adjustments for age, obesity-related factors, and prostate volume.
Nishimura K; Soda T; Nakazawa S; Yamanaka K; Hirai T; Kishikawa H; Ichikawa Y
Minerva Urol Nefrol; 2012 Sep; 64(3):199-208. PubMed ID: 22971685
[TBL] [Abstract][Full Text] [Related]
13. Obesity, adipokines, and prostate cancer in a prospective population-based study.
Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
[TBL] [Abstract][Full Text] [Related]
14. Role of adiponectin in obesity related gastrointestinal carcinogenesis.
Nagaraju GP; Aliya S; Alese OB
Cytokine Growth Factor Rev; 2015 Feb; 26(1):83-93. PubMed ID: 25007742
[TBL] [Abstract][Full Text] [Related]
15. [Influence of leptin and adiponectin on prostate cancer].
Lopez Fontana CM; Maselli Artola ME; Di Milta Monaco N; Recalde Rincon GM; Vanrell Rodriguez MC; Uvilla Recupero A; Messina Lombino D; Perez Elizalde RF; Lopez Laur JD
Arch Esp Urol; 2009 Mar; 62(2):103-8. PubMed ID: 19448276
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin, an anti-carcinogenic hormone? A systematic review on breast, colorectal, liver and prostate cancer.
Perrier S; Jardé T
Curr Med Chem; 2012; 19(32):5501-12. PubMed ID: 22876928
[TBL] [Abstract][Full Text] [Related]
17. Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies.
Petridou ET; Mitsiades N; Gialamas S; Angelopoulos M; Skalkidou A; Dessypris N; Hsi A; Lazaris N; Polyzos A; Syrigos C; Brennan AM; Tseleni-Balafouta S; Mantzoros CS
Oncology; 2007; 73(3-4):261-9. PubMed ID: 18424891
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer and adiponectin.
Goktas S; Yilmaz MI; Caglar K; Sonmez A; Kilic S; Bedir S
Urology; 2005 Jun; 65(6):1168-72. PubMed ID: 15922427
[TBL] [Abstract][Full Text] [Related]
19. [Role of adiponectin in prostate cancer: A preliminary study].
Fu S; Xu H; Liu C; Gu M; Wang Q; Zhou J; Wang Z
Zhonghua Nan Ke Xue; 2017 Nov; 23(11):975-981. PubMed ID: 29738161
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin-induced antitumor activity on prostatic cancers through inhibiting proliferation.
Gao Q; Zheng J
Cell Biochem Biophys; 2014 Sep; 70(1):461-5. PubMed ID: 24793551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
